
ChemoCentryx Inc (NASDAQ:CCXI) shares are trading higher by 21.45% at $19.00 after the company reported first-quarter results.
ChemoCentryx reported quarterly losses of 55 cents per share which missed the analyst consensus estimate of a loss of 30 cents. The company also reported quarterly sales of $5.46 million which missed the analyst consensus estimate of $22.04 million.